The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,733.00
Ask: 1,734.00
Change: 5.00 (0.29%)
Spread: 1.00 (0.058%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: SABMiller Accepts Improved AB InBev Offer

Tue, 13th Oct 2015 09:43

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.
----------
FTSE 100 - WINNERS
----------
SABMiller, up 9.0% at 3,946.50 pence. The Anglo-South African brewing giant has reached a deal to be acquired by larger rival Anheuser-Busch InBev, which increased its offer to GBP44 per share from GBP43.50 on day previously. A formal offer at that price would value SABMiller at GBP71.28 billion, with the combination of the two companies to create a global beer giant with a roughly GBP280 billion market cap. AB InBev now has until 1700 BST on October 28 to decide whether to make an firm offer or walk away.

GlaxoSmithKline, up 1.0% at 1,318.50 pence. JPMorgan upgraded the pharmaceutical company to Neutral from Underweight, and raised its price target to 1,370 pence from 1,320p.
----------
FTSE 100 - LOSERS
----------
Royal Mail, down 4.3% at 451.90 pence. The UK government said it has sold the majority of its 14% stake in Royal Mail PLC for around GBP591.0 million under an accelerated bookbuilding process announced the previous day. The government sold a 13% stake in Royal Mail, comprising around 130.0 million shares, at a placing price of 455.0 pence per share. The remaining 1% stake, equivalent to about 10.0 million shares, will be "gifted" to Royal Mail employees in the UK, marking the government's final disposal of shares.

Barclays, down 2.9%. The lender reportedly plans to name JPMorgan investment banker Jes Staley as its new chief executive, with confirmation to come in the next two weeks depending on regulatory approval. Such a move would put a high profile investment banker in charge at a time when there are big questions about the role of Barclays' investment banking division. Under the ousted Antony Jenkins, a retail banker, Barclays had set about reducing its overall reliance on the division as a source of earnings.

Glencore, down 5.4%. The commodities trader and mining company was down due to concerns about China's economy health. Anglo American, another miner, was down 3.3% and BHP Billiton down 2.0%. China's exports declined at a moderate pace in September as the devaluation of yuan helped it from falling sharply amid weak global demand. At the same time, imports plunged due to a drop in commodity prices and subdued domestic demand.
----------
FTSE 250 - WINNERS
----------
Bellway, up 3.5%. The housebuilder said it should be able to grow volumes by up to 10% in its current financial year, as it reported a 44% jump in pretax profit to GBP354.2 million in the year ended July 31 and raised its dividend to 77.0 pence from 52.0p.

Michael Page International, up 2.1%. The recruitment consultancy said Non-Executive Chairman Robin Buchanan plans to step down, as it reiterated its expectations for its full year. The company said its gross profit in the third quarter of 2015 rose 4.8% to GBP139.2 million from GBP132.9 million in the previous year. This growth was hit by volatility in foreign exchange rates, and at constant currency gross profit would have risen 10.2%.

Sophos Group, up 3.3% at 232.00 pence. Liberum initiated coverage of the security software and hardware developer at Buy with a 290p price target, saying the company has attractive cash dynamics and expects its earnings before interest, taxes, depreciation and amortisation to more than double over the next five years.
----------
FTSE 250 - LOSERS
----------
Weir Group, down 3.7% at 1,298.00 pence. The engineering company was hit by broker price-target cuts. Morgan Stanley cut its price target on Weir Group to 1,200 pence from 1,360p, and reiterated its Underweight rating. Meanwhile, UBS cut its price target on the company to 1,800p from 2,000p, and reiterated a Buy rating.
----------
MAIN MARKET AND AIM - WINNERS
----------
Flybe Group, up 6.6%. The airline on Tuesday boasted double-digit increases in seat capacity, passenger numbers and revenue in its second quarter, but reported a slight decline in passenger load factor.

Mediazest, up 34%. The audio-visual products company said it has secured new business worth a cumulative GBP1.0 million since announcing full-year results in August. It also had won new clients including Diesel SpA, Molson Coors Brewing Co and the John Lewis Partnership, and signed new business with existing clients, such as Hyundai Motor Co, Adidas AG and the Post Office Ltd.

RWS Holdings, up 18%. The patent translation and search company said it enjoyed a "significant" recovery in the second half of its last financial year, a boost after the flat sales performance in the opening six months of the year. The 2% increase in full-year sales, which reached GBP95.1 million, means the numbers were ahead of market expectations prior to the announcement.
----------
MAIN MARKET AND AIM - LOSERS
----------

Arrow Global, down 9.4% at 246.25 pence. Chief Executive Tom Drury, Chief Financial Officer Robert Memmott and other executives, together with an unnamed institutional investor, sold GBP27.5 million of shares in the debt manager. The 11 million shares were sold at 250 pence apiece overnight Monday to Tuesday. They represent a combined stake of 6.3%.

Galantas Gold Corp, down 14%. The company said that an individual intends to challenge its application for planning permission to allow the company to mine underneath the open pit at the Cavanacaw mine in Northern Ireland.

Auhua Clean Energy, down 14%. Chairman David Sumner has resigned due to "increasing demands on his time from his other business commitments", the company said. Raphael Tham has assumed the role of non-executive chairman. Tham was previously vice-chairman.
----------

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.